RE:I am a champion... I understand your frustration but I cant see what positive news or events or anything they can say.
We already know that Q-1 revenues are in line with achieving the Yearly guidance for 2023....Unless there is a drastic overdelivery in the sales I dont think re affirming guidance would move the needle
With regards to TH 1902 we will know soon but What can they say until final determination
We know their position in Nash which is a pause until they find a partner ....They surely wont disclose anything until they have finalised an agreement
I am crossing my fingers that they have the necessary funds to pay the balance of the damn Convert in June ..... Cash is the big problem ....and survival is the focus for now....Cant change that situation with hype!!!!
A partner in Nash with a substantial down payments would change things overnight
1902??? Dont know what to expect
scarlet1967 wrote: They are well engaged with HIV communities which is great as for investors we saw an example of how/when they should be informed from Akero's PR. Starting with logos they go on talking about "positive" meeting with FDA, anticipated "details" of their trial....
Note the talks with FDA are still ongoing yet Akero decided to inform the market about it's progress!
As for THTX to my knowledge they never announced NDA's for NASH or oncology, approvals of applications in timely manner instead they decided to bundle up the "good" news and release them some 3 or more months later. Two different strategies one with current and more frequent updates the other one with longer spans of time between updates. As an investor I personally absolutely prefer the former approach, too many unknowns unnecessarily stop any new investors from getting involved therefore Akero and the likes feed the market with as much current information as they can which is the only right way of getting investors educated/excited and hopeful. I did send an email to IR today asking them once again to change their communication strategies as I find it extremely hard to understand why they keep using the same failed communication strategy.
https://www.fiercepharma.com/marketing/theratechnologies-champions-showcases-thriving-minority-individuals-living-hiv